OKYO Pharma Ltd — insider transactions

3 transactions on record · OKYO · CIK 1849296

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$75K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$35K
2026-07-20
Director share, 12m
100.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$75K
purchases minus sales
Total on record
3

Transactions

3 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-232026-07-212BRANCACCIO JOHN PDirectorGrant or award5,000$1.48$7.4Kfiling
2026-07-232026-07-212CERRONE GABRIELE MDirector, 10% OwnerGrant or award22,500$1.45$32.6Kfiling
2026-07-212026-07-201CERRONE GABRIELE MDirector, 10% OwnerGrant or award25,000$1.40$35Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

OKYO Pharma Ltd insider transactions — 3 filings on record — Tapewire